-
Medical journals
- Career
Use of Ruthenuim 106 in Retinoblastoma Treatment
Authors: P. Pochop 1; J. Mališ 2; B. Šímová 2; J. Malec 1; P. Palkosková 3
Authors‘ workplace: Oční klinika dětí a dospělých, UK 2. LF a FN Motol, Praha přednosta doc. MUDr. D. Dotřelová, CSc. 1; Klinika dětské onkologie a hematologie, UK 2. LF a FN Motol, Praha přednosta prof. MUDr. J. Starý, DrSc. 2; Radioterapeuticko-onkologické odd. FN Motol, Praha primář MUDr. J. Prausová 3
Published in: Čes. a slov. Oftal., 61, 2005, No. 3, p. 192-197
Overview
The Charles University Teaching Hospital in Prague – Motol started to treat patients with retinoblastoma by means of brachytherapy after obtaining the permission to use closed source of ionizing radiation in the beginning of the year 2003. The applicator containing ruthenium (106Ru) emitting mostly the beta radiation was chosen. Half-life is 369 days and the nominal activity of the source is 21.1 MBq. The applicator is placed in place for one to several days according to the prominence of the tumor and actual activity of the source. Duration of the application is calculated with a special program. In the year 2003, three patients with retinoblastoma were treated. In one case bilateral involvement was determined, and the brachytherapy was used for treatment of both eyes. The next patient was treated twice; one treatment followed the other with different localization of the applicator because of too large basis of the tumor. In 2003, altogether the brachytherapy was used for treatment of retinoblastoma five times. In all cases, the combined treatment (chemo reduction, teletherapy, transpupillary thermotherapy, or cryotherapy) was performed. One eyeball was enucleated because of severe post-radiation retinopathy, the second one for persisting tractional retinal detachment. In remaining cases no serious complications or progression of the malignancy were observed.
Key words:
brachytherapy, retinoblastoma, ionizing radiation, radioisotope, ruthenium, closed source of ionizing radiation, ocular applicator
Labels
Ophthalmology
Article was published inCzech and Slovak Ophthalmology
2005 Issue 3-
All articles in this issue
- Changes of Physiological Intraocular Pressure (IOP) in Rabbits after Amino Acid Lysine with Antiglaucomatic Drug Latanoprost (Xalatan)
- Transpupillary Thermotherapy in Exsudative Age-related Macular Degeneration. Two-Years Results and Findings on the Other Eye
- The Results of Radiotherapy 24 Months after Treatment by Patients with Agerelated Macular Degeneration
- Perforating Pars Plana Sclerotomy in Idiopathic Uveal Effusion Syndrome
- Terson’s Syndrome, Pars Plana Vitrectomy and Anatomical and Functional Outcome
- Surgical Treatment of Late Tractional Retinal Detachment Appearing on the Basis of Retinopathy of Prematurity
- Use of Ruthenuim 106 in Retinoblastoma Treatment
- Comparison of Accuracy of Refraction Measurement in Children up to the Age of 15 Years by Eccentric Phototrefraction and by Standard Techniques
- Effect of Laser in situ Keratomileusis on LogMAR Visual Acuity and Contrast Sensitivity
- Spontaneous Late Subluxation of Capsule, Intraocular Lens and Capsular Ring in Patient with Pseudoexfoliation Syndrome – a Case Report
- Congenital Stationary Night Blindness (CSNB) – a Case Report
- Czech and Slovak Ophthalmology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Terson’s Syndrome, Pars Plana Vitrectomy and Anatomical and Functional Outcome
- Congenital Stationary Night Blindness (CSNB) – a Case Report
- Spontaneous Late Subluxation of Capsule, Intraocular Lens and Capsular Ring in Patient with Pseudoexfoliation Syndrome – a Case Report
- Perforating Pars Plana Sclerotomy in Idiopathic Uveal Effusion Syndrome
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career